﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Merck news stories on Newser</title><description>Read more Merck stories on Newser</description><link>http://www.newser.com/taggrid/1171/merck.html</link><copyright>2009 - Newser</copyright><language>en-us</language><generator>Newser Feed Generator</generator><pubDate>Tue, 24 Nov 2009 9:51:32 CST</pubDate><item><guid isPermaLink="true">http://www.newser.com/story/74122/drugmakers-hike-prices-ahead-of-reform.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Drugmakers Hike Prices Ahead of Reform</title><description>Bracing for health care reform, drug companies have been raising prices at the fastest rate in almost 20 years—even as they pledge to support Washington's goal of cutting the nation's drug bill. The pharmaceutical industry is scrambling to get the price base as high as possible before legislation to...</description><link>http://www.newser.com/story/74122/drugmakers-hike-prices-ahead-of-reform.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Mon, 16 Nov 2009 7:08:02 CST</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/67271/cervical-cancer-vaccine-linked-to-32-deaths.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Cervical Cancer Vaccine Linked to 32 Deaths</title><description>Gardasil, the cervical cancer vaccine marketed to teen girls, has been linked to 32 deaths and other serious side effects including fainting and blood clots, according to a government report released yesterday. Since 2006, several complications of the vaccine have been reported, ABC News reports, ranging from neurological disorders to...</description><link>http://www.newser.com/story/67271/cervical-cancer-vaccine-linked-to-32-deaths.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Wed, 19 Aug 2009 12:16:58 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/65255/tech-snaps-nadaqs-streak-dow-climbs-24.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Tech Snaps Nadaq's Streak; Dow Climbs 24</title><description>The tech sector exerted downward pressure on stocks today, snapping the Nasdaq’s 12-day winning streak, the Wall Street Journal reports. Microsoft sank 8.9% after reporting a 29% drop in quarterly earnings, while Amazon fell 8.3% after also reporting a disappointing quarter. Alcoa, Pfizer, and Merck helped the Dow...</description><link>http://www.newser.com/story/65255/tech-snaps-nadaqs-streak-dow-climbs-24.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Fri, 24 Jul 2009 15:24:21 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/61714/spending-on-health-care-lobbying-up-41.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Spending on Health Care Lobbying Up 41%</title><description>As the health care debate heats up in Washington, insurance and drug companies are keeping their lobbyists busy. So far this year, those industries have increased their lobbyist spending by 41% as they fight a proposed public insurance plan, USA Today reports. That's $35 million in the first quarter for...</description><link>http://www.newser.com/story/61714/spending-on-health-care-lobbying-up-41.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Fri, 12 Jun 2009 11:45:01 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/58786/drugs-oil-push-dow-up-50.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Drugs, Oil Push Dow Up 50</title><description>Financials dipped today as firms continued stock sell-offs to finance TARP repayments, but strong performance by drug and energy companies stabilized the market, the Wall Street Journal reports. Merck and Pfizer were up as much as 2% and 6%, respectively; oil got a boost from $60 barrels. The Dow was...</description><link>http://www.newser.com/story/58786/drugs-oil-push-dow-up-50.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Tue, 12 May 2009 15:15:20 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/56766/earnings-send-stocks-south.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Earnings Send Stocks South</title><description>Stocks slid at the open this morning, after a rash of less-than-inspiring earnings reports from major companies. The Dow was down 30 points, as components Coca-Cola, Caterpillar, Dupont, and Merck all posted lousy first quarters. Caterpillar swung to a loss and slashed guidance, sending shares down 5%, while Dupont fell...</description><link>http://www.newser.com/story/56766/earnings-send-stocks-south.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Tue, 21 Apr 2009 8:40:51 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/54419/push-to-use-hpv-vaccine-on-boys-stirs-debate.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Push to Use HPV Vaccine on Boys Stirs Debate</title><description>Merck is pushing the FDA to approve its HPV vaccine for men, and that’s raising a whole new set of controversies, the Washington Post reports. When the human papillomavirus vaccine was originally marketed for girls, many questioned whether or not it would encourage young girls to have sex. With boys...</description><link>http://www.newser.com/story/54419/push-to-use-hpv-vaccine-on-boys-stirs-debate.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Thu, 26 Mar 2009 8:58:15 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/53277/dow-up-54-gains-9-for-week.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Dow Up 54, Gains 9% for Week</title><description>Stocks made gains today, extending a winning streak into its fourth day, MarketWatch reports. Merck rose 12.5% on announcement of its merger with Schering-Plough, while General Motors built on recent gains with a 22.9% jump. The Dow closed up 53.92 at 7,223.98. The Nasdaq rose...</description><link>http://www.newser.com/story/53277/dow-up-54-gains-9-for-week.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Fri, 13 Mar 2009 15:20:02 CDT</pubDate></item><item><guid isPermaLink="true">http://www.newser.com/story/52802/merck-to-buy-schering-plough-in-latest-pharma-merger.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</guid><title>Merck to Buy Schering-Plough in Latest Pharma Merger</title><description>Merck announced today that it will merge with fellow drugmaker Schering-Plough in a $41.1 billion cash-and-stock deal to enlarge its pipeline of new drugs in development, reports the Wall Street Journal . The two companies have already collaborated on cholesterol drug Zetia—whose sales plummeted after a study questioned its...</description><link>http://www.newser.com/story/52802/merck-to-buy-schering-plough-in-latest-pharma-merger.html?utm_source=syn&amp;utm_medium=rss&amp;utm_campaign=tag</link><pubDate>Mon, 09 Mar 2009 6:34:37 CDT</pubDate></item></channel></rss>